MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Diagnostic Utility of [18F]FDG-PET in the Differential Diagnosis of Parkinsonian Syndromes: A Retrospective Study in an Indian Tertiary Care Cohort

    A. Mani, J. Hephzibah (Ranipet, India)

  • Diagnostic Utility of Routine 1.5T Brainstem Planimetry in Parkinsonism: Evidence from a Vietnamese Cohort

    D. Nguyen, T. Tran (St Lucia, Australia)

  • Diagnostic Validity of PD Identification in a Neurologist-Certified National Drug Reimbursement Registry

    V. Räty, T. Kuusimäki, T. Vahlberg, A-M. Tolppanen, V. Kaasinen (Turku, Finland)

  • Diet Quality and Nutrient Intake in Parkinson’s Disease: A Multicenter Study in Egypt

    E. Abed (Cairo, Egypt)

  • Dietary and Environmental Risk Factors of Parkinson’s Disease: An Integrated Network Pharmacology Approach

    D. Ghosh, P. Basu, S. Mondal, S. Dey, S. Pal (Kolkata, India)

  • Differences in Levodopa Equivalent Daily Dose (LEDD) Based on Disease Duration in Parkinson’s Disease Patients at RSCM – A Tertiary National Referral Hospital

    F. Abdat, A. Tiksnadi, D. Tungjungsari (Jakarta, Indonesia)

  • Differences in Lewy body dementia in people from ethnic minorities: a systematic review of epidemiology, diagnosis, clinical features and imaging

    S. Kalam, A. Zirra, J. Knight, L. Bishop, R. Fernando, C. Marshall, A. Noyce, R. Weil (London, United Kingdom)

  • Differences in Sleep and Activity Digital Phenotypes from Wrist Accelerometry in Parkinson’s Disease, At‑Risk Individuals, and Healthy Controls

    I. Gerasimou, A. Moustaklis, L. Hadjileontiadis, S. Hadjidimitriou (Thessaloniki, Greece)

  • Differential Cholinergic White Matter Microstructural Alterations in Multiple System Atrophy and Parkinson’s Disease

    SM. Rong, R. Yang, ZH. Li, XL. Cui, CT. He, MF. Cai, YH. Zhang (Guangzhou, Guangdong Province, China)

  • Differential Effect of MAO-B Inhibitors in GBA1 Carriers with Parkinson’s Disease Women vs Men

    H. Saragani, R. Henner, M. Cohen, S. Vilk, A. Zimran, I. Harari, R. Eichel, G. Yahalom, M. Cohen (Jerusalem, Israel)

  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley